Pfizer Inc. stock at EUR 26.31 ahead of the Xetra open: biopharma group little changed
Published on 10/19/2026 at 07:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness and upcoming date
- Pfizer develops medicines and vaccines in the biopharmaceutical market.
- Pfizer lists a webcast with analysts for November 3, 2026.
- Pfizer Inc. stock trades pre-market at EUR 26.31 at 7:32 a.m. CEST at Lang & Schwarz on October 19, 2026, plus 0.04 percent above the Xetra close of October 16, 2026.
Pfizer develops medicines and vaccines for patients worldwide, according to its corporate website. Pfizer Inc. stock trades pre-market at EUR 26.31 at 7:32 a.m. CEST at Lang & Schwarz on October 19, 2026, plus 0.04 percent above the Xetra close of October 16, 2026 (EUR 26.30).
Ahead of the Xetra open
The indication is EUR plus 0.01 versus the reference close, with a bid of EUR 26.25 and an ask of EUR 26.38. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Pfizer Inc. stock.
The group and its calendar
Pfizer operates in the biopharmaceutical market, developing medicines and vaccines across areas including vaccines and oncology. Its homepage lists a webcast with analysts for November 3, 2026, and identifies Pfizer as a biopharmaceutical company. Market context: Market report S&P 500.
